Abstract
In this concise report, we describe the history and evolution of childhood acute leukemia studies in Brazil, and the application if key biomarkers for clinical trials and epidemiological studies over the past 8 years. Highlights of each ongoing study are summarized. A Brazilian network integrating hospitals and scientific institutions from all country regions has been established. This organization is made possible through informatics and computer networking, and the standardization of pathological reviews including immunophenotyping and molecular characterization of childhood leukemias. The unique characteristics of the Brazilian population combined with a large clinical and epidemiologic framework for patient ascertainment has enabled large-scale epidemiological studies on childhood leukemia in Brazil.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Acute Disease
-
Adolescent
-
Biomarkers, Tumor
-
Brazil / epidemiology
-
Child
-
Child, Preschool
-
Disease Susceptibility
-
Down Syndrome / epidemiology
-
Down Syndrome / genetics
-
Female
-
Forecasting
-
GATA1 Transcription Factor / genetics
-
Genetic Predisposition to Disease
-
Genotype
-
Histone-Lysine N-Methyltransferase
-
Hospitals / statistics & numerical data
-
Humans
-
Immunophenotyping
-
Incidence
-
Infant
-
Information Services / organization & administration
-
Leukemia / epidemiology*
-
Leukemia / genetics
-
Leukemia / immunology
-
Male
-
Myeloid-Lymphoid Leukemia Protein / genetics
-
Registries / statistics & numerical data
Substances
-
Biomarkers, Tumor
-
GATA1 Transcription Factor
-
GATA1 protein, human
-
KMT2A protein, human
-
Myeloid-Lymphoid Leukemia Protein
-
Histone-Lysine N-Methyltransferase